.gif)
Stay informed with Dubai Investments’ latest press releases, featuring key announcements, strategic initiatives, and industry insights. Explore our updates to stay connected with our growth, innovations, and contributions to the UAE’s dynamic economy.
September 17, 2026
Globalpharma, a wholly owned subsidiary of Dubai Investments and one of the UAE's leading pharmaceutical manufacturers, has signed a Memorandum of Understanding (MoU) with PrinceFarma, an Angola-based pharmaceutical distribution company, to advance pharmaceutical distribution in Angola.
The collaboration will focus on advancing regulatory alignment and establishing commercial and distribution frameworks for Globalpharma's portfolio in Angola, including the identification of priority therapeutic areas and structured pathways for market development.
The MoU was signed by Mohammed Saeed Al Raqbani, General Manager of Dubai Investments Industries and Masharie and Board Director at Globalpharma and Aziz Rahemani, Managing Director of PrinceFarma Group.
Read More
Dubai Investments warns all investors to verify the identity of the entity they are dealing with before signing any agreements or making any financial transactions, and to refer to Data related to licensed companies published on the Dubai Financial Market’s website in order to avoid exposure to any fraudulent operations by unknown entities.
✓ Success
